Heron Therapeutics | HRTX - القيمة السوقية





القيمة السوقية تغيير تاريخ
ALKERMES USD 5.88B 1.26B 2026-03
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Amarin USD 290M 51M 2025-12
ANI Pharmaceuticals USD 1.75B 24M 2026-03
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 8.78B 236M 2026-03
Eisai JPY 1.42T 110.62B 2026-03
Emergent BioSolutions USD 125M 51M 2023-12
Esperion Therapeutics USD 885M 351M 2025-12
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
Heron Therapeutics USD 238M 7M 2025-12
Insmed USD 35.3B 1.82B 2026-03
Ligand Pharmaceuticals USD 3.98B 241M 2026-03
Merck USD 297.1B 35.84B 2026-03
Nektar Therapeutics USD 11.91B 11.05B 2026-06
Neurocrine Biosciences USD 13.25B 890M 2026-03
Pacira USD 915M 149M 2026-03
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Roche Holding CHF 266.34B 55.46B 2025-12
Ultragenyx Pharmaceutical USD 2.06B 159M 2026-03
Veracyte USD 2.57B 758M 2026-03
Vertex Pharmaceuticals USD 113.58B 1.44B 2026-03